| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,144,000 | 3,684,000 | 2,602,000 | 2,067,000 | | Cost of Revenue | 1,967,000 | 2,286,000 | 1,592,000 | 3,342,000 | | | Gross Profit | 2,177,000 | 1,398,000 | 1,010,000 | (1,275,000) | | | Operating Expenses | | Research Development | 73,000 |
-
|
-
| (209,000) | | Selling General and Administrative | 20,000 | 124,000 | 81,000 | 261,000 | | Non Recurring |
-
| (2,000) | 25,000 | 16,965,000 | | Others |
-
| (232,000) | 232,000 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,084,000 | 1,508,000 | 672,000 | (18,292,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (14,000) | (3,000) | (14,000) | (19,000) | | Earnings Before Interest And Taxes | 1,650,000 | 1,505,000 | 658,000 | (18,311,000) | | Interest Expense | (289,000) | 158,000 | 131,000 | 140,000 | | Income Before Tax | 1,939,000 | 1,347,000 | 527,000 | (18,451,000) | | Income Tax Expense | 684,000 | 542,000 | 331,000 | (4,471,000) | | Minority Interest |
-
|
-
|
-
| 131,000 | | | | Net Income From Continuing Ops | 735,000 | 812,000 | 207,000 | (13,850,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 735,000 | 812,000 | 207,000 | (13,850,000) | | Preferred Stock And Other Adjustments | 214,000 | (224,000) | (164,000) | (83,000) | | | Net Income Applicable To Common Shares | $925,000 | $588,000 | $43,000 | ($13,933,000) |
|
0.31% Nasdaq 
0.05%
Income Statement
